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The relationship of rat brain spectrin isoforms to microtubules of newborn and adult animals was studied. Spectrins were minor components in 
microtubule preparations. The microtubule-associated spectrin is a major calmodulin-binding protein. Radiolabelled brain spectrin(240/235) re- 
vealed specific microtubule binding activity in vitro, possibly via a tubulin. 
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1. INTRODUCTION 
Brain spectrin, an essential component of the mem- 
brane-related cytoskeleton [ 12,191, links cytoplasmic 
actin filaments to the plasma membrane [lo]. It was 
also referred to as ‘fodrin’ [ 161, and as ‘brain-calmodu- 
lin-binding protein’ [7,11], however, the significance of 
such calmodulin binding is as yet not clear. Brain spec- 
trin was shown to induce bundling of microtubules in 
vitro [ 141. A major amount of brain spectrin co-isolated 
with microtubules under non-depolymerizing condi- 
tions, but such microtubules lost brain spectrin in 
subsequent cycles of cold and warm centrifugations [9]. 
The issue is further complicated by the identification of 
two brain spectrin isoforms in mammalian brain tissue, 
named brain spectrin(240/235) and brain spectrin- 
(240/235E) with differential location and development- 
dependent appearance [ 17,181. In contrast to brain 
spectrin(240/235) which was found in neuroblasts and 
axons, brain spectrin(240/235E), an immunologically 
related protein to red blood cell spectrin, appeared late 
during postnatal brain development in perikarya and 
dendrites of differentiating neurons, and in some glial 
cells [la]. The relationship of these two brain spectrin 
isoforms to microtubules during development has not 
been investigated and is the issue of this study. 
2. MATERIALS AND METHODS 
Bruin microtubules were isolated from newborn and adult 
Sprague-Dawley rats by 3 cycles of cold and warm centrifugations 
[20]. The third microtubule pellet (MT3) was dissolved in 0.1 M MES 
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(pH 7.4), 1 mM EGTA, 0.5 mM MgClz, 1 mM GTP to obtain 9 mg 
microtubule proteins/ml and were centrifuged at 4°C at 100000 x g 
for 20 min. The soluble microtubule proteins were used for the 
microtubule sedimentation assay. 
Brain specfrin(250/235) was isolated as described [17]. IOOcg pro- 
tein was labeled with Na[L251] by the method of Bolton and Hunter 
[4], and dialysed against blot overlay- or microtubule-sedimentation 
assay buffer. The specific radioactivity of labeled brain spectrin was 
6.5 x lo5 cpm/pg brain spectrin(2401235). 
Ca/modulin was isolated and biotinylated by standard procedures 
111. 
Profein amounts were determined by the Bio-Rad protein dye 
assay. 
Electrophoresis and Immunoblots: Protein samples were separated 
on SDS-PAGE 1151 and stained with Coomassie blue R250, or 
transferred to nitrocellulose sheets [21]. Western blots were probed 
with poly- and monoclonal antibodies and peroxidase-conjugated 
secondary antibodies and reaction was visualized with 4-chloro-l- 
naphthol [17]. 
All antibodies have been previously described: Rabbit polyclonal 
antibodies against spectrin/240/235) and (2401235E) and pre- 
immune serum [17]; and monoclonal antibodies against MAP2 1131, 
z- [2], ,&tubulin [3]. 
Blot overlay: Calmodulin binding to proteins on Western blots was 
demonstrated by biotinylated calmodulin, avidin-conjugated alkaline 
phosphatase, and Nitroblue tetrazolium chloride and 5-bromo-4- 
chloro-3 inoyl phosphate p-toluidine salt as chromogens [I]. 1 mM 
EGTA abolished biotinylated calmodulin-binding to proteins on 
blots. Brain spectrin(240/235) binding was also determined by a blot 
overlay method [8]. ‘251-labeled brain spectrin(240/235) was used at 
2.3 x lo5 cpm/ml. Dried blots were exposed to Kodak XARS film for 
65 h at -20°C. In control experiments a IO-fold excess of unlabeled 
brain spectrin(240/235) reduced binding of iodinated brain spectrin to 
proteins on blot. 
Microtubule-sedimentation assay: For this assay proteins were used 
at a final concentration of 1 fig ‘251-labeled brain spectrin- 
(240/235)/ml with, or without 3 mg microtubule proteins/ml, and 10 
pg brain spectrin(240/235)/ml. Proteins were incubated for 30 min at 
37°C in motility buffer of Vale et al. [22] including protease inhibitors 
leupeptin and antipain (10 rg/ml). Aliquots of 200 pl were overlayed 
on top of a 200 pl cushion of 30% glycerol in motility buffer and 
centrifuged for 30 min at 39 000 x g at room temperature. Superna- 
tant and pellet fractions were counted for radioactivity and submitted 
to electrophoresis and autoradiography. Each measurement was done 
at least in triplicate. 
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3. RESULTS 
3.1. Spectrins in microtubule preparations 
A 
123 
C 
123 
Both brain spectrin isoforms as well as contaminating 
red blood cell spectrin were present in microtubule 
preparations. They are minor components making up 
less than 0.1% of microtubule proteins. On Western 
blots the antibody against brain spectrin(240/235) 
reacted with with 240 kDa subunit of brain spectrin pre- 
sent in both newborn and adult microtubules (Fig. 1, 
lane 3 and 4). Little brain spectrin(240/235E) was 
detected by an antibody which was raised against rbc 
spectrin and usually reacts strongly with the 235 kDa 
brain spectrin subunit. It was seen as faint staining of 
the 240 kDa and 235 kDa brain spectrin(240/235E) 
subunits in microtubule preparations of adult animals 
(Fig. 1, lane 6). This 235 kDa protein staining was lack- 
ing in microtubules of newborn rats (lane 5); but the 
staining of two other proteins of 240 kDa and 220 kDa 
in the same sample indicated the presence of rbc spec- 
trin subunits possibly due to the presence of con- 
taminating erythrocytes in the microtubule preparation. 
3.2. Brain spectrin(240123S) binding to microtubules 
The ability of brain spectrin(240/235) to bind to 
microtubules was demonstrated in a microtubule- 
sedimentation assay. Without the presence of micro- 
tubule proteins in the assay 87.0 f 8.4% (n = 4) of lz51- 
labeled brain spectrin(240/235) remained in the super- 
natant. When microtubule proteins were present in the 
assay, radiolabeled brain spectrin was binding to micro- 
tubule proteins, and was found to be 58.7 + 16.0% in 
the pellet fraction. With addition of a ten-fold excess of 
brain spectrin(240/235) to microtubule proteins and 
radiolabeled brain spectrin, the radioactive brain spec- 
trin remained in the supernatant fraction (with 
72.1% f 5.2%). Electrophoresis and autoradiography 
Fig. 2. Calmodulin-binding and ‘L’I-labeled brain spectrin binding by 
blot overlay. Adult rat brain tissue (lane l), microtubules of adult rats 
(lane 2) and rat brain spectrin(2401235) (lane 2) were separated on a 
4-12’70 SDS-PAGE. Western blots were stained with Amido black 
(A), or used for the calmodulin blot overlay (B), or for the blot 
overlay with radiolabeled brain spectrin(240/235) (C). The M, is in- 
dicated on the left in kDa. Arrows point to cy- and &tubulins. 
of corresponding aliquots confirmed these findings 
(data not shown). 
3.3. Calmodulin-[‘251Jbrain spectrin/240/235)-, and 
immuno-blot overlay 
In Fig. 2B the calmodulin blot overlay showed the 
240 kDa spectrin subunit as a major calmodulin binding 
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Fig. 1. Brain microtubule preparations of newborn animals (lanes 1, 3 and 5) and adult rats (lanes 2,4 and 6) were separated on a 4% SDS-PAGE. 
Gels were stained with Coomassie blue (lanes 1 and 2) and blots were stained for brain spectrin(240/235) (lanes 3 and 4), and for brain spec- 
trin(240/235E) (lanes 5 and 6). The M, is indicated on the right in kDa. The location of microtubule-associated proteins 1 to 5 and spectrin(s) are 
indicated on the left. Only the relevant portions of the gels and blots are shown. 
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Fig. 3. SDS-electrophoresis and Western blots of microtubules (lanes 
1) and brain spectrin (lanes 2), isolated from adult rat brain. 4-15% 
SDS-PAGE were stained with Coomassie blue (A), or blots were pro- 
bed with anti-MAP2 (B), anti-r- (C) or anti-fi-tubulin (D). M, values 
are indicated on the left in kDa. 
protein in adult rat brain tissue (lane l), in a micro- 
tubule preparation (lane 2), and in purified brain spec- 
trin (lane 3). The autoradiography of a blot overlay 
with radiolabeled brain spectrin(240/235) in Fig. 2C in- 
dicated that brain spectrin(240/235) had the tendency 
to self-association (lanes 1 and 3). In a microtubule 
fraction (lane 2) the radioactively labeled brain spectrin 
exhibited binding to proteins in the M, range of tubulins 
(indicated by arrows). 
In Fig. 3, Western blots of microtubules (lane 1) and 
of purified brain spectrin(240/235) (lane 2) were probed 
with monoclonal antibodies against MAP2, 7 or ,& 
tubulin and showed that all 3 antibodies reacted spe- 
cifically with MAP2, 7 or ,&tubulin in the microtubule 
preparation (Fig. 3B-D, lane 1). However, only a trace 
of ,&tubulin was found present in purified brain spec- 
trin (Fig. 3D, lane 2). 
4. CONCLUSIONS 
The results presented suggest that all spectrin 
isoforms have limited ability to co-isolate with 
microtubules through several temperature-dependent 
centrifugation cycles. The difference, that only brain 
spectrin(240/235) but not (240/235E) binds to micro- 
tubules of newborn animals, could be explained by that 
brain spectrin(2401235) is present in fetal and newborn 
tissue while brain spectrin(2401235E) appears at later 
stages during development and is not present at birth 
[ 181. Our results on brain spectrin-microtubule binding 
are in agreement with previous studies [5,9,14] and fur- 
thermore suggest that brain spectrin may bind to micro- 
tubules of juvenile and adult animals. The binding site 
for brain spectrin is possibly a tubulin form with a high 
brain spectrin binding affinity but which is present at 
low abundancy in microtubules - what could explain 
the low tubulin labeling efficiency by radioactive brain 
spectrin (Fig. 2C, lane 2). For erythrocyte spectrin the 
binding site in microtubules was shown to be a T-protein 
[5], but it remains to be seen if the red blood cell 
spectrin-related brain spectrin(240/235E) also binds to 
T-proteins once its isolation procedure has been esta- 
blished. 
Brain spectrin was shown to be a major calmodulin- 
binding protein in postsynaptic densities [6]. In addi- 
tion, our data suggest hat brain spectrin may be a ma- 
jor calmodulin-binding protein in association with 
microtubules. It remains to be determined if both brain 
spectrin isoforms bind calmodulin equally well. An 
immuno-electron microscopic study has shown that 
both brain spectrin isoforms occur along microtubules 
[23], and therefore such a brain spectrin coat along 
microtubules, with the ability to bind calmodulin could 
be of significance for the stabilization of microtubule 
and for the regulation of calmodulin-dependent en- 
zymatic processes. 
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